Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries

Completed · Phase 2

Conditions studied: Peripheral Nerve Injuries

In brief

NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 16 and 80 years of age.

Key facts

Study ID
NCT04572906
Run by
Neuraptive Therapeutics Inc.
People needed
51
Starts
2020-09-25
Expected to finish
2024-06-27
Last updated by the study team
2024-11-20

Who can join

Age: 12 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.